| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III | Singer S.; Ara?jo C.; Arraras J.I.; Baumann I.; Boehm A.; Brokstad Herlofson B.; Castro Silva J.; WEI-CHU CHIE ; Fisher S.; Guntinas-Lichius O.; Hammerlid E.; Irarr?zaval M.E.; Jensen Hjermstad M.; Jensen K.; Kiyota N.; Licitra L.; Nicolatou-Galitis O.; Pinto M.; Santos M.; Schmalz C.; Sherman A.C.; Tomaszewska I.M.; Verdonck De Leeuw I.; Yarom N.; Zotti P.; Hofmeister D. | Head and Neck | 57 | 50 | |
| 2013 | Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy - Update of the EORTC QLQ-H&N35, Phase i | Singer S.; Arraras J.I.; Baumann I.; Boehm A.; WEI-CHU CHIE ; Galalae R.; Langendijk J.A.; Guntinas-Lichius O.; Hammerlid E.; Pinto M.; Nicolatou-Galitis O.; Schmalz C.; Sen M.; Sherman A.C.; Spiegel K.; Verdonck-De Leeuw I.; Yarom N.; Zotti P.; Hofmeister D. | Head and Neck | 24 | 25 | |
| 2021 | SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity | Sherman A.C.; Desjardins M.; CHI-AN CHENG ; Bausk B.; Izaguirre N.; Zhou G.; Krauss J.; Tolan N.; Walt D.R.; Soiffer R.; Ho V.T.; Issa N.C.; Baden L.R. | Clinical Infectious Disease | 11 | 15 |
